Stay updated on Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record is displayed in place of a 403 Forbidden page, showing its trial details, eligibility criteria, locations, outcomes, and publications.
    Difference
    100%
    Check dated 2026-11-09T13:44:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:45:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the clinical-trial page, which displays a 403 error.
    Difference
    1%
    Check dated 2026-10-26T14:13:20.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T14:09:54.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:42:52.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, blocking access to the NCT01761266 details. The page displays an error message and site chrome instead of the trial information.
    Difference
    18%
    Check dated 2026-09-21T22:01:31.000Z thumbnail image

Stay in the know with updates to Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Lenvatinib vs Sorafenib in Hepatocellular Carcinoma Clinical Trial page.